Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário

Detalhes bibliográficos
Ano de defesa: 2016
Autor(a) principal: Silva, Valdelena Alessandra da lattes
Orientador(a): Camacho, Cléber Pinto lattes
Banca de defesa: Camacho, Cléber Pinto lattes, Cury, Adriano Namo lattes, Silva Junior, Jose Antonio lattes
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Nove de Julho
Programa de Pós-Graduação: Programa de Mestrado em Medicina
Departamento: Saúde
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://bibliotecatede.uninove.br/handle/tede/3025
Resumo: Hypothyroidism is the inadequate production of thyroid hormone or the inappropriate action of thyroid hormone on target tissues. Among thyroid dysfunctions, hypothyroidism is the most common disorder in the general population, particularly in women. Levothyroxine sodium (L-T4) is considered the drug of choice and most effective as a replacement or supplementation treatment in patients with hypothyroidism worldwide. The aim of this study was to provide a panel of gene expression to mark the therapeutic response of levothyroxine in patients with primary hypothyroidism. We selected 4 control subjects and 8 subjects with levothyroxine therapy, 4 of whom were euthyroid with adequate treatment, with serum TSH between 0.4mIU/L and 4.0mIU/L, and 4 subclinical hypothyroidism with inadequate treatment with TSH Between 4.1mIU/L and 20.0mIU/L. Samples of 5mL of venous blood were collected and stored in PAXgene RNA tubes. RNA extraction was performed with the PAXgene RNA extraction kit (Qiagen). The transcriptome library was created on an NGS platform, Ion AmpliSeq Gene human transcriptome. Mann-Whitney was used to compare the two groups. Continuous variables are presented as median, minimum and maximum values, and Kruskal-Wallis was used to compare the three groups. Correlation between transcripts, TSH and Zulewski: Spearman's method. The data analyzed using IBM SPSS Statistics. The computational data analysis was performed in software RStudio, Package EdgeR v 3.12.0 of Bioconductor. Significant genes are calculated after a False Discovery Response (FDR) setting. A p<0.05 was considered significant. Differential expression analysis revealed 179 with increase and 174 with decrease in expression, being 289 mRNA and 64 non-coding RNA. Of these, 2 genes (CXCR6 and HTR4) showed an absolute value of the reads relatively high. We constructed a panel capable of identifying patients with an inadequate response to levothyroxine treatment. We identified transcripts that could compose a panel for the evaluation of gene expression, serving as biomarkers for the diagnosis of primary hypothyroidism, even in individuals with TSH concentrations close to the reference values. In addition to marking the response to the use of levothyroxine, CXCR6 and HTR4, they may be useful in evaluating the tissue repercussion of hypothyroidism.
id NOVE_e15beeb747e18ab4534ce7dd86b65b00
oai_identifier_str oai:localhost:tede/3025
network_acronym_str NOVE
network_name_str Biblioteca Digital de Teses e Dissertações da Uninove
repository_id_str
spelling Camacho, Cléber Pintohttp://lattes.cnpq.br/1832800364435894Camacho, Cléber Pintohttp://lattes.cnpq.br/1832800364435894Cury, Adriano Namohttp://lattes.cnpq.br/7133785713614688Silva Junior, Jose Antoniohttp://lattes.cnpq.br/1990427833073161http://lattes.cnpq.br/5214549027860250Silva, Valdelena Alessandra da2022-08-01T14:35:03Z2016-12-12Silva, Valdelena Alessandra da. Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário. 2016. 105 f. Dissertação( Programa de Mestrado em Medicina) - Universidade Nove de Julho, São Paulo.http://bibliotecatede.uninove.br/handle/tede/3025Hypothyroidism is the inadequate production of thyroid hormone or the inappropriate action of thyroid hormone on target tissues. Among thyroid dysfunctions, hypothyroidism is the most common disorder in the general population, particularly in women. Levothyroxine sodium (L-T4) is considered the drug of choice and most effective as a replacement or supplementation treatment in patients with hypothyroidism worldwide. The aim of this study was to provide a panel of gene expression to mark the therapeutic response of levothyroxine in patients with primary hypothyroidism. We selected 4 control subjects and 8 subjects with levothyroxine therapy, 4 of whom were euthyroid with adequate treatment, with serum TSH between 0.4mIU/L and 4.0mIU/L, and 4 subclinical hypothyroidism with inadequate treatment with TSH Between 4.1mIU/L and 20.0mIU/L. Samples of 5mL of venous blood were collected and stored in PAXgene RNA tubes. RNA extraction was performed with the PAXgene RNA extraction kit (Qiagen). The transcriptome library was created on an NGS platform, Ion AmpliSeq Gene human transcriptome. Mann-Whitney was used to compare the two groups. Continuous variables are presented as median, minimum and maximum values, and Kruskal-Wallis was used to compare the three groups. Correlation between transcripts, TSH and Zulewski: Spearman's method. The data analyzed using IBM SPSS Statistics. The computational data analysis was performed in software RStudio, Package EdgeR v 3.12.0 of Bioconductor. Significant genes are calculated after a False Discovery Response (FDR) setting. A p<0.05 was considered significant. Differential expression analysis revealed 179 with increase and 174 with decrease in expression, being 289 mRNA and 64 non-coding RNA. Of these, 2 genes (CXCR6 and HTR4) showed an absolute value of the reads relatively high. We constructed a panel capable of identifying patients with an inadequate response to levothyroxine treatment. We identified transcripts that could compose a panel for the evaluation of gene expression, serving as biomarkers for the diagnosis of primary hypothyroidism, even in individuals with TSH concentrations close to the reference values. In addition to marking the response to the use of levothyroxine, CXCR6 and HTR4, they may be useful in evaluating the tissue repercussion of hypothyroidism.O hipotiroidismo é a produção inadequada de hormônio da glândula tiroide ou a ação inadequada de hormônio tiroidiano em tecidos-alvo. Entre as disfunções da tiroide, o hipotiroidismo é o distúrbio mais frequente na população em geral, particularmente em mulheres. A levotiroxina sódica (L-T4) é considerado o fármaco de escolha e mais eficaz como tratamento de reposição ou suplementação nos pacientes com hipotiroidismo em todo o mundo. O objetivo deste estudo foi o de originar um painel de expressão gênica para marcar a resposta terapêutica da levotiroxina em pacientes com hipotiroidismo primário. Foram selecionados 4 indivíduos controle e 8 indivíduos com terapia de levotiroxina, em que 4 são eutiroidianos com tratamento adequado, com TSH sérico entre 0,4mUI/L e 4,0mUI/L, e 4 hipotiroidismo subclínico com tratamento inadequado, com TSH entre 4,1mUI/L e 20,0mUI/L. Amostras de 5mL de sangue venoso foram recolhidas e armazenados em tubos de PAXgene RNA. A extração de RNA foi realizada com o kit de extração de RNA PAXgene (Qiagen). A biblioteca de transcriptoma foi criada em uma plataforma de NGS, Ion AmpliSeq Gene human transcriptome. Mann-Whitney foi usado para comparar os dois grupos. As variáveis contínuas são apresentadas como valores medianos, mínimos e máximos, e Kruskal-Wallis foi usado para comparar os três grupos. Correlação entre os transcritos, TSH e Zulewski: Método de Spearman. Os dados analisados usando o IBM SPSS Statistics. A análise computacional de dados foi realizada em software RStudio, Pacote EdgeR v 3.12.0 de Bioconductor. Os genes significativos são calculados após um ajuste de False Discovery Response (FDR). Foi considerado significante um p<0,05. A análise de expressão diferencial revelou 179 com aumento e 174 com diminuição na expressão, sendo 289 RNAm e 64 RNA não codificantes. Destes, 2 genes (CXCR6 e HTR4) mostraram um valor absoluto dos reads relativamente alto. Construímos um painel capaz de identificar pacientes com resposta inadequada ao tratamento com levotiroxina. Identificamos transcritos, que poderão compor um painel para a avaliação da expressão gênica, servindo como biomarcadores para o diagnóstico do hipotiroidismo primário, mesmo em indivíduos com concentrações de TSH próximas dos valores de referência. Além de marcar a resposta ao uso de levotiroxina, CXCR6 e HTR4, poderão ter utilidade na avaliação da repercussão tecidual do hipotiroidismo.Submitted by Nadir Basilio (nadirsb@uninove.br) on 2022-08-01T14:35:03Z No. of bitstreams: 1 Valdelena Alessandra da Silva.pdf: 4037107 bytes, checksum: 7b0e5e299fae748666c01a4f6e01f9ab (MD5)Made available in DSpace on 2022-08-01T14:35:03Z (GMT). No. of bitstreams: 1 Valdelena Alessandra da Silva.pdf: 4037107 bytes, checksum: 7b0e5e299fae748666c01a4f6e01f9ab (MD5) Previous issue date: 2016-12-12application/pdfporUniversidade Nove de JulhoPrograma de Mestrado em MedicinaUNINOVEBrasilSaúdetiroidehipotiroidismo primáriolevotiroxinaRNA-seqeficácia terapêuticaexpressão gênicathyroidprimary hypothyroidismlevothyroxineRNA-seqtherapeutic efficacygene expressionCIENCIAS DA SAUDEAnálise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primárioGene expression analysis as a parameter of therapeutic effectiveness in levothyroxine patients with primary hypothyroidisminfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis8765449414823306929600info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da Uninoveinstname:Universidade Nove de Julho (UNINOVE)instacron:UNINOVEORIGINALValdelena Alessandra da Silva.pdfValdelena Alessandra da Silva.pdfapplication/pdf4037107http://localhost:8080/tede/bitstream/tede/3025/2/Valdelena+Alessandra+da+Silva.pdf7b0e5e299fae748666c01a4f6e01f9abMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://localhost:8080/tede/bitstream/tede/3025/1/license.txtbd3efa91386c1718a7f26a329fdcb468MD51tede/30252022-08-01 11:35:03.865oai:localhost: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Biblioteca Digital de Teses e Dissertaçõeshttp://bibliotecatede.uninove.br/PRIhttp://bibliotecatede.uninove.br/oai/requestbibliotecatede@uninove.br||bibliotecatede@uninove.bropendoar:2022-08-01T14:35:03Biblioteca Digital de Teses e Dissertações da Uninove - Universidade Nove de Julho (UNINOVE)false
dc.title.por.fl_str_mv Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
dc.title.alternative.eng.fl_str_mv Gene expression analysis as a parameter of therapeutic effectiveness in levothyroxine patients with primary hypothyroidism
title Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
spellingShingle Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
Silva, Valdelena Alessandra da
tiroide
hipotiroidismo primário
levotiroxina
RNA-seq
eficácia terapêutica
expressão gênica
thyroid
primary hypothyroidism
levothyroxine
RNA-seq
therapeutic efficacy
gene expression
CIENCIAS DA SAUDE
title_short Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
title_full Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
title_fullStr Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
title_full_unstemmed Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
title_sort Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário
author Silva, Valdelena Alessandra da
author_facet Silva, Valdelena Alessandra da
author_role author
dc.contributor.advisor1.fl_str_mv Camacho, Cléber Pinto
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/1832800364435894
dc.contributor.referee1.fl_str_mv Camacho, Cléber Pinto
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/1832800364435894
dc.contributor.referee2.fl_str_mv Cury, Adriano Namo
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/7133785713614688
dc.contributor.referee3.fl_str_mv Silva Junior, Jose Antonio
dc.contributor.referee3Lattes.fl_str_mv http://lattes.cnpq.br/1990427833073161
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/5214549027860250
dc.contributor.author.fl_str_mv Silva, Valdelena Alessandra da
contributor_str_mv Camacho, Cléber Pinto
Camacho, Cléber Pinto
Cury, Adriano Namo
Silva Junior, Jose Antonio
dc.subject.por.fl_str_mv tiroide
hipotiroidismo primário
levotiroxina
RNA-seq
eficácia terapêutica
expressão gênica
topic tiroide
hipotiroidismo primário
levotiroxina
RNA-seq
eficácia terapêutica
expressão gênica
thyroid
primary hypothyroidism
levothyroxine
RNA-seq
therapeutic efficacy
gene expression
CIENCIAS DA SAUDE
dc.subject.eng.fl_str_mv thyroid
primary hypothyroidism
levothyroxine
RNA-seq
therapeutic efficacy
gene expression
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE
description Hypothyroidism is the inadequate production of thyroid hormone or the inappropriate action of thyroid hormone on target tissues. Among thyroid dysfunctions, hypothyroidism is the most common disorder in the general population, particularly in women. Levothyroxine sodium (L-T4) is considered the drug of choice and most effective as a replacement or supplementation treatment in patients with hypothyroidism worldwide. The aim of this study was to provide a panel of gene expression to mark the therapeutic response of levothyroxine in patients with primary hypothyroidism. We selected 4 control subjects and 8 subjects with levothyroxine therapy, 4 of whom were euthyroid with adequate treatment, with serum TSH between 0.4mIU/L and 4.0mIU/L, and 4 subclinical hypothyroidism with inadequate treatment with TSH Between 4.1mIU/L and 20.0mIU/L. Samples of 5mL of venous blood were collected and stored in PAXgene RNA tubes. RNA extraction was performed with the PAXgene RNA extraction kit (Qiagen). The transcriptome library was created on an NGS platform, Ion AmpliSeq Gene human transcriptome. Mann-Whitney was used to compare the two groups. Continuous variables are presented as median, minimum and maximum values, and Kruskal-Wallis was used to compare the three groups. Correlation between transcripts, TSH and Zulewski: Spearman's method. The data analyzed using IBM SPSS Statistics. The computational data analysis was performed in software RStudio, Package EdgeR v 3.12.0 of Bioconductor. Significant genes are calculated after a False Discovery Response (FDR) setting. A p<0.05 was considered significant. Differential expression analysis revealed 179 with increase and 174 with decrease in expression, being 289 mRNA and 64 non-coding RNA. Of these, 2 genes (CXCR6 and HTR4) showed an absolute value of the reads relatively high. We constructed a panel capable of identifying patients with an inadequate response to levothyroxine treatment. We identified transcripts that could compose a panel for the evaluation of gene expression, serving as biomarkers for the diagnosis of primary hypothyroidism, even in individuals with TSH concentrations close to the reference values. In addition to marking the response to the use of levothyroxine, CXCR6 and HTR4, they may be useful in evaluating the tissue repercussion of hypothyroidism.
publishDate 2016
dc.date.issued.fl_str_mv 2016-12-12
dc.date.accessioned.fl_str_mv 2022-08-01T14:35:03Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv Silva, Valdelena Alessandra da. Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário. 2016. 105 f. Dissertação( Programa de Mestrado em Medicina) - Universidade Nove de Julho, São Paulo.
dc.identifier.uri.fl_str_mv http://bibliotecatede.uninove.br/handle/tede/3025
identifier_str_mv Silva, Valdelena Alessandra da. Análise da expressão gênica como parâmetro da eficácia terapêutica da levotiroxina em pacientes com hipotiroidismo primário. 2016. 105 f. Dissertação( Programa de Mestrado em Medicina) - Universidade Nove de Julho, São Paulo.
url http://bibliotecatede.uninove.br/handle/tede/3025
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 8765449414823306929
dc.relation.confidence.fl_str_mv 600
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Nove de Julho
dc.publisher.program.fl_str_mv Programa de Mestrado em Medicina
dc.publisher.initials.fl_str_mv UNINOVE
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Saúde
publisher.none.fl_str_mv Universidade Nove de Julho
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da Uninove
instname:Universidade Nove de Julho (UNINOVE)
instacron:UNINOVE
instname_str Universidade Nove de Julho (UNINOVE)
instacron_str UNINOVE
institution UNINOVE
reponame_str Biblioteca Digital de Teses e Dissertações da Uninove
collection Biblioteca Digital de Teses e Dissertações da Uninove
bitstream.url.fl_str_mv http://localhost:8080/tede/bitstream/tede/3025/2/Valdelena+Alessandra+da+Silva.pdf
http://localhost:8080/tede/bitstream/tede/3025/1/license.txt
bitstream.checksum.fl_str_mv 7b0e5e299fae748666c01a4f6e01f9ab
bd3efa91386c1718a7f26a329fdcb468
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da Uninove - Universidade Nove de Julho (UNINOVE)
repository.mail.fl_str_mv bibliotecatede@uninove.br||bibliotecatede@uninove.br
_version_ 1800312443173339136